Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen

References

• Stehlik J Edwards LB Kucheryavaya AY The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report – 2011 J Heart Lung Transplant 2011 30 10 1078 1094 21962016
   PubMed Web of Science ®Google Scholar
• Guethoff S Meiser BM Groetzner J Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation Transplantation 2013 95 4 629 634 23423270
   PubMed Web of Science ®Google Scholar
• Todo S Fung JJ Demetris AJ Jain A Venkataramanan R Starzl TE Early trials with FK 506 as primary treatment in liver transplantation Transplant Proc 1990 22 1 13 16 1689886
   PubMed Web of Science ®Google Scholar
• Starzl TE Fung J Jordan M Kidney transplantation under FK 506 JAMA 1990 264 1 63 67 1693970
   PubMed Web of Science ®Google Scholar
• Armitage JM Kormos RL Fung J Preliminary experience with FK 506 in thoracic transplantation Transplantation 1991 52 1 164 167 1713363
   PubMed Web of Science ®Google Scholar
• Armitage JM Kormos RL Griffith BP A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation Transplant Proc 1991 23 1 Pt 2 1149 1152 1703336
   PubMed Web of Science ®Google Scholar
• Azzi JR Sayegh MH Mallat SG Calcineurin inhibitors: 40 years later, can’t live without … J Immunol 2013 191 12 5785 5791 24319282
   PubMed Web of Science ®Google Scholar
• Kino T Hatanaka H Miyata S FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro J Antibiot (Tokyo) 1987 40 9 1256 1265 2445722
   PubMed Web of Science ®Google Scholar
• Ho ET Wong G Craig JC Chapman JR Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review Transplantation 2013 95 9 1120 1128 23542469
   PubMed Web of Science ®Google Scholar
• Kobashigawa JA Miller LW Russell SD Study Investigators Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs cyclosporine with MMF in cardiac transplant patients: 1-year report Am J Transplant 2006 6 6 1377 1386 16686761
   PubMed Web of Science ®Google Scholar
• Mehra MR Uber PA Scott RL Park MH Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression Transplantation 2002 74 11 1568 1573 12490790
   PubMed Web of Science ®Google Scholar
• Sánchez-Lázaro IJ Almenar L Martínez-Dolz L A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantation Clin Transplant 2011 25 4 606 613 20682020
   PubMed Web of Science ®Google Scholar
• Grimm M Rinaldi M Yonan NA Superior prevention of acute rejection by tacrolimus vs cyclosporine in heart transplant recipients – a large European trial Am J Transplant 2006 6 6 1387 1397 16686762
   PubMed Web of Science ®Google Scholar
• Lund LH Edwards LB Kucheryavaya AY International Society for Heart and Lung Transplantation The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report – 2013; focus theme: age J Heart Lung Transplant 2013 32 10 951 964 24054804
   PubMed Web of Science ®Google Scholar
• Stewart S Winters GL Fishbein MC Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 2005 24 11 1710 1720 16297770
   PubMed Web of Science ®Google Scholar
• Levey AS Bosch JP Lewis JB Greene T Rogers N Roth D A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 1999 130 6 461 470 10075613
   PubMed Web of Science ®Google Scholar
• Wang CH Ko WJ Chou NK Wang SS Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan Transplant Proc 2004 36 8 2384 2385 15561256
   PubMed Web of Science ®Google Scholar
• Doesch AO Mueller S Akyol C Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation Drug Des Devel Ther 2013 7 1253 1258
   PubMed Web of Science ®Google Scholar
• Meiser BM Groetzner J Kaczmarek I Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? Transplantation 2004 78 4 591 598 15446320
   PubMed Web of Science ®Google Scholar
• Zezina L Vessby B Larsson E Backman U Fellström B Carvedilol treatment of kidney graft recipients with chronic rejection Clin Transplant 1999 13 6 484 490 10617238
   PubMed Web of Science ®Google Scholar
• Ekberg H Tedesco-Silva H Demirbas A ELITE-Symphony Study Reduced exposure to calcineurin inhibitors in renal transplantation N Engl J Med 2007 357 25 2562 2575 18094377
   PubMed Web of Science ®Google Scholar
• Penninga L Møller CH Gustafsson F Steinbrüchel DA Gluud C Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials Eur J Clin Pharmacol 2010 66 12 1177 1187 20882273
   PubMed Web of Science ®Google Scholar
• Ye F Ying-Bin X Yu-Guo W Hetzer R Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis J Heart Lung Transplant 2009 28 1 58 66 19134532
   PubMed Web of Science ®Google Scholar